Pricing Log in Create free account

Tiziana Life Sciences Ltd (TLSA) vs Voyager Therapeutics, Inc. (VYGR)

Tiziana Life Sciences Ltd and Voyager Therapeutics, Inc. are both Biotechnology companies. Tiziana Life Sciences Ltd and Voyager Therapeutics, Inc. are of similar size ($134.7M and $126.9M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −312.6%) and the higher return on invested capital (0.00% vs −192.6%). Across the 12 metrics below, Tiziana Life Sciences Ltd leads on 9 and Voyager Therapeutics, Inc. on 3.

Valuation

Metric TLSA VYGR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.34 9.71
P/B n/m 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.04 0.01 0.64
EV/Sales n/m (0.04) 9.21
Earnings yield (49.89%) (95.26%) (33.15%)
Free cash flow yield 0.00% (105.54%) (25.50%)

Profitability

Metric TLSA VYGR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin — (340.08%) 0.00%
Net margin 0.00% (312.63%) 0.00%
Free cash flow margin 0.00% (352.36%) 0.00%
Return on equity 0.00% (54.09%) (56.36%)
Return on assets 0.00% (41.45%) (48.04%)
Return on invested capital 0.00% (192.55%) 0.00%

Growth

Metric TLSA VYGR Biotechnology median
Revenue growth (TTM) — (19.07%) 6.02%
EPS growth (last fiscal year) (45.45%) (80.53%) 30.26%
Revenue growth, 5-year CAGR — (25.09%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TLSA VYGR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 7.51 4.72
Net debt to EBITDA 0.19 1.50 0.96

Dividend

Metric TLSA VYGR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TLSA VYGR Biotechnology median
Market cap 134.73m 126.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack